The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0
|
作者：
Ueda, M [1 ]
Hirokane, G [1 ]
Morita, S [1 ]
Yokono, A [1 ]
Okawa, M [1 ]
Shimoda, K [1 ]
机构：
[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [31] Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia
    Kosuke Doki
    Masato Homma
    Keisuke Kuga
    Kazutomi Kusano
    Shigeyuki Watanabe
    Iwao Yamaguchi
    Yukinao Kohda
    European Journal of Clinical Pharmacology, 2006, 62 : 919 - 926
  • [32] Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia
    Kosuke Doki
    Masato Homma
    Keisuke Kuga
    Kazutomi Kusano
    Shigeyuki Watanabe
    Iwao Yamaguchi
    Yukinao Kohda
    European Journal of Clinical Pharmacology, 2007, 63 : 217 - 218
  • [33] Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
    Berecz, R
    Llerena, A
    de la Rubia, A
    Gómez, J
    Kellermann, M
    Dorado, P
    Degrell, I
    PHARMACOPSYCHIATRY, 2002, 35 (06) : 231 - 234
  • [34] Using CYP2D6 genotype to understand paroxetine-pimozide pharmacokinetics in man
    Foot, Elizabeth
    Briley, Linda
    McCarthy, Linda
    Moate, Rachel
    Reck, Brian
    Muir, Keith
    Stapleton, Carole
    Cox, Charles
    Dow, David
    Mehta, Nalini
    Latham, Ian
    Goodgame, Neil
    Vousden, Marika
    Nucci, Gianluca
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 786 - 786
  • [35] Pharmacokinetics of atomoxetine after administration of paroxetine in relation to CYP2D6 genotype status
    Kim, Dong-Hyun
    Lim, Hye-Jin
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    PHARMACOTHERAPY, 2015, 35 (11): : E316 - E317
  • [36] Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol
    Yasui-Furukori, N
    Kondo, T
    Suzuki, A
    Mihara, K
    Tokinaga, N
    Inoue, Y
    Otani, K
    Kaneko, S
    SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) : 139 - 142
  • [37] Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression
    Komahashi-Sasaki, Hazuki
    Yasui-Furukori, Norio
    Sasaki, Taro
    Shinozaki, Masataka
    Hayashi, Yuki
    Kato, Kazuko
    Inoue, Yoshimasa
    Tsuchimine, Shoko
    Watanabe, Takashi
    Sugawara, Norio
    Shimoda, Kazutaka
    THERAPEUTIC DRUG MONITORING, 2021, 43 (05) : 681 - 687
  • [38] Effect of CYP2D6*10 polymorphism on mirtazapine metabolism in Japanese psychiatric patients
    Watanabe, T.
    Hyashi, Y.
    Aoki, A.
    Ishiguro, S.
    Inoue, Y.
    Akiyama, K.
    Tsuchimine, S.
    Yasui-Furukori, N.
    Shimoda, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S462 - S463
  • [39] Relationship of venlafaxine, fluoxetine, sertraline, and paroxetine plasma concentration with CYP 2D6 inhibition
    Alfaro, C
    Ereshefsky, L
    Lam, YWF
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 488 - 488
  • [40] The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients
    Mihara, K
    Otani, K
    Tybring, G
    Dahl, ML
    Bertilsson, L
    Kaneko, S
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (06) : 467 - 471
12345